Company Description
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services.
In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations.
Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names.
The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022.
Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
| Country | United States |
| Founded | 1944 |
| Industry | Healthcare Plans |
| Sector | Healthcare |
| Employees | 104,900 |
| CEO | Gail Boudreaux |
Contact Details
Address: 220 Virginia Avenue Indianapolis, Indiana 46204 United States | |
| Phone | 833 401 1577 |
| Website | elevancehealth.com |
Stock Details
| Ticker Symbol | ELV |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001156039 |
| CUSIP Number | 036752103 |
| ISIN Number | US0367521038 |
| Employer ID | 35-2145715 |
| SIC Code | 6324 |
Key Executives
| Name | Position |
|---|---|
| Gail Koziara Boudreaux | President, Chief Executive Officer and Director |
| Mark Bradley Kaye | Executive Vice President and Chief Financial Officer |
| Blair Williams Todt | Executive Vice President and Chief Legal and Administrative Officer |
| Peter David Haytaian Esq. | Executive Vice President and President of Carelon and CarelonRx |
| Felicia Farr Norwood | Executive Vice President and President of Government Health Benefits |
| Scott Wayne Anglin | SVice President, Treasurer and Chief Investment Officer |
| Ronald William Penczek | Senior Vice President, Controller and Chief Accounting Officer |
| Stephen Vartan Tanal C.F.A. | Vice President of Investor Relations |
| Julie Goon | Senior Vice President of Public Affairs |
| Kyle Weber | Chief Strategy Officer and Interim Chief Marketing Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 23, 2024 | 424B3 | Prospectus |
| Oct 22, 2024 | FWP | Free Writing Prospectus |
| Oct 22, 2024 | 424B3 | Prospectus |
| Oct 18, 2024 | 144 | Filing |
| Oct 17, 2024 | 10-Q | Quarterly Report |
| Oct 17, 2024 | 8-K | Current Report |
| Aug 5, 2024 | 144 | Filing |
| Jul 22, 2024 | 144 | Filing |